RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+10.77%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$4.58B
AUM Growth
+$4.58B
(-2.1%)
Cap. Flow
+$43.2M
Cap. Flow
% of AUM
0.94%
Top 10 Holdings %
Top 10 Hldgs %
23.53%
Holding
172
New
18
Increased
60
Reduced
32
Closed
20
Top Buys
| 1 |
Immunocore
IMCR
|
$97.6M |
| 2 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$73M |
| 3 |
Bolt Biotherapeutics
BOLT
|
$51.3M |
| 4 |
Cullinan Oncology
CGEM
|
$44.8M |
| 5 |
AstraZeneca
AZN
|
$32.3M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$54.5M |
| 2 |
UnitedHealth
UNH
|
$48.4M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$47.9M |
| 4 |
Centene
CNC
|
$43.8M |
| 5 |
Immunovant
IMVT
|
$41.2M |
Sector Composition
| 1 | Healthcare | 93.74% |
| 2 | Consumer Staples | 1.75% |
| 3 | Industrials | 0.62% |
| 4 | Financials | 0.12% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Agios Pharmaceuticals
AGIO
$2.19B
| $131M | 2.87% | 2,543,600 +20,079 | +0.8% | +$1.04M |
|
2
Humana
HUM
$36.5B
| $126M | 2.75% | 301,000 +16,000 | +6% | +$6.71M |
|
3
Zai Lab
ZLAB
$3.68B
| $125M | 2.72% | 933,500 +78,601 | +9% | +$10.5M |
|
4
Atea Pharmaceuticals
AVIR
$267M
| $105M | 2.28% | 1,694,903 -2,500 | -0.1% | -$154K |
|
|
5
UnitedHealth
UNH
$281B
| $102M | 2.23% | 275,000 -130,000 | -32% | -$48.4M |
|
|
FPRX
6
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $100M | 2.19% | 2,660,822 +1,939,189 | +269% | +$73M |
|
|
7
Neurocrine Biosciences
NBIX
$13.8B
| $98.7M | 2.15% | 1,015,000 -560,000 | -36% | -$54.5M |
|
|
8
Immunocore
IMCR
$1.62B
| $97.6M | 2.13% | +2,292,285 | New | +$97.6M |
|
9
Insulet
PODD
$23.9B
| $96.8M | 2.11% | 371,000 +53,000 | +17% | +$13.8M |
|
10
Align Technology
ALGN
$10.3B
| $96.1M | 2.1% | 177,500 +14,000 | +9% | +$7.58M |
|
11
Aclaris Therapeutics
ACRS
$209M
| $89.9M | 1.96% | 3,569,192 +893,092 | +33% | +$22.5M |
|
12
Intuitive Surgical
ISRG
$170B
| $88.7M | 1.93% | 120,000 | – | – |
|
13
Idexx Laboratories
IDXX
$51.8B
| $88.1M | 1.92% | 180,000 +55,000 | +44% | +$26.9M |
|
14
HCA Healthcare
HCA
$94.5B
| $84.8M | 1.85% | 450,000 | – | – |
|
|
NVTA
15
DELISTED
Invitae Corporation
NVTA
| $84.6M | 1.85% | 2,213,977 +361,910 | +20% | +$13.8M |
|
16
Novavax
NVAX
$1.21B
| $83.6M | 1.82% | 461,000 -102,205 | -18% | -$18.5M |
|
17
argenx
ARGX
$43.6B
| $82.6M | 1.8% | 300,000 +12,500 | +4% | +$3.44M |
|
18
Freshpet
FRPT
$2.72B
| $80.4M | 1.75% | 506,500 | – | – |
|
19
Exact Sciences
EXAS
$8.98B
| $75.1M | 1.64% | 570,000 +85,000 | +18% | +$11.2M |
|
|
BPMC
20
DELISTED
Blueprint Medicines
BPMC
| $72.6M | 1.58% | 746,732 -95,268 | -11% | -$9.26M |
|
21
Pacira BioSciences
PCRX
$1.2B
| $71.8M | 1.57% | 1,025,000 | – | – |
|
|
ONC
22
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $69.6M | 1.52% | 200,000 -25,000 | -11% | -$8.7M |
|
|
NVRO
23
DELISTED
NEVRO CORP.
NVRO
| $67.7M | 1.48% | 485,000 +90,000 | +23% | +$12.6M |
|
24
iRhythm Technologies
IRTC
$5.46B
| $60.1M | 1.31% | 432,496 -192,504 | -31% | -$26.7M |
|
|
HZNP
25
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $57.5M | 1.26% | 625,000 | – | – |
|